Bifidobacterium breve MCC1274 alleviates AD-like pathology in WT mice by reducing the level of presenilin1 protein and phosphorylated tau protein, reducing the level of soluble Aβ 42 in hippocampus, alleviating neuroinflammation and improving the level of synaptic protein. The gene discussed is MAPT; the disease is Alzheimer disease.